The KIAA1549-BRAF fusion gene, resulting from duplication of the BRAF gene at 7q34, is used as a marker of tumor derived cells and phenotypically distinct tumor cells expressing vascular markers; it is the most frequent genetic alteration in PA (>70%) [19]. This evidence concerns the gene BRAF and neoplasm.